![]() |
|
|
Vol. 55, Issue 3, 541-547, March 1999
Department of Biochemistry, Institute of Cellular Signalling, University of Nijmegen, Nijmegen, the Netherlands
| |
Summary |
|---|
|
|
|---|
Gastric H+,K+-ATPase can be inhibited by imidazo pyridines like 2-methyl-8-[phenylmethoxy] imidazo-(1,2a) pyridine 3-acetonitrile (SCH 28080). The drug shows a high affinity for inhibition of K+-activated ATPase and for prevention of ATP phosphorylation. The inhibition by SCH 28080 can be explained by assuming that SCH 28080 binds to both the E2 and the phosphorylated intermediate (E2-P) forms of the enzyme. We observed recently that some mutants, in which glutamic acid 820 present in transmembrane domain six of the catalytic subunit had been replaced (E820Q, E820N, E820A), lost their K+-sensitivity and showed constitutive ATPase activity. This ATPase activity could be inhibited by similar SCH 28080 concentrations as the K+-activated ATPase of the wild-type enzyme. SCH 28080 also inhibited ATP phosphorylation at 21°C of the mutants E820D, E820N, and E820A, although with varying efficacy and affinity. ATP-phosphorylation of mutant E820Q was not inhibited by SCH 28080; in contrast, the phosphorylation level at 21°C was nearly doubled. These findings can be explained by assuming that mutation of Glu820 favors the E1 conformation in the order E820Q >E820A >E820N >wild-type = E820D. The increase in the phosphorylation level of the E820Q mutant can be explained by assuming that during the catalytic cycle the E2-P intermediate forms a complex with SCH 28080. This intermediate hydrolyzes considerably slower than E2-P and thus accumulates. The high tendency of the E820Q mutant for the E1 form is further supported by experiments showing that ATP phosphorylation of this mutant is rather insensitive towards vanadate, inorganic phosphate, and K+.
| |
Introduction |
|---|
|
|
|---|
Gastric
H+,K+-ATPase, a P-type ATPase, is responsible
for gastric acid secretion. The enzyme is located in the
tubulovesicular system of the parietal cell and is translocated to the
apical plasma membrane after hormonal stimulation. It catalyzes an
electroneutral transport of K+ versus H+
energized by ATP hydrolysis. Gastric
H+,K+-ATPase can be reversibly inhibited by
imidazo pyridines like 2-methyl-8-[phenylmethoxy]
imidazo-(1,2a) pyridine 3-acetonitrile (SCH 28080),
apparently by binding to a high-affinity site for K+
(Wallmark et al., 1987
, Keeling et al., 1989
; Mendlein and Sachs, 1990
). Munson et al. (1991)
determined the binding site of a
photoaffinity analog of SCH 28080 to be the domain including the first
two transmembrane segments of the
-subunit as well as the
extracellular loop between these segments. Lyu and Farley (1997)
recently reported that Na+,K+-ATPase, in which
twelve amino acids of the first transmembrane segment of the
-subunit had been replaced by the homologous amino acids from
H+,K+-ATPase, showed a rather high sensitivity
toward this drug. This suggests that the N terminal part of the
-subunit of H+,K+-ATPase is the main
participant in SCH 28080 binding, as it is in the binding of ouabain to
Na+,K+-ATPase (Lingrel and Kuntzweiler, 1994
).
On the other hand, Asano et al. (1997)
suggested recently that glutamic
acid 820 might also be important for the binding of SCH 28080.
Recently, we prepared in Sf9 insect cells with aid of the baculovirus
expression system a series of mutants of rat gastric H+,K+-ATPase in which glutamic acid 820, located in the 6th transmembrane domain of the
-subunit, had been
replaced by various amino acids (Hermsen et al., 1998
). All mutants
(E820D, E820A, E820Q, and E820N) could, like the wild-type enzyme, be
phosphorylated by ATP. The hydrolysis of the phosphorylated
intermediate (E-P) of mutant E820D could, like that of the wild-type
enzyme, be enhanced by 1 mM K+. This mutant showed a
normal K+-stimulated ATPase activity with a maximal
activity at 1 mM K+. The dephosphorylation of the E-P of
the E820Q and E820N mutants could not be stimulated by K+
and that of the E820A mutant only at 100 mM K+. Similarly,
the ATPase activity of the E820Q and E820N mutants was not stimulated
by K+, whereas, that of the E820A mutant was only slightly
increased at 100 mM K+. For clarity, these three mutants
are coined in the present paper as "K+-insensitive
mutants".
Preincubation of the wild-type enzyme at 0°C with SCH 28080, a
specific inhibitor of gastric H+,K+-ATPase,
resulted in a decrease of the ATP phosphorylation level with an
IC50 value of 20 nM (see Table
1). Similar IC50 values were
obtained for the mutants E820D and E820N. The E820A mutant, however,
was less sensitive to SCH 28080 and phosphorylation of the E820Q mutant
could hardly be reduced by this compound. Thus, the three
K+-insensitive mutants have a different apparent affinity
for SCH 28080 when ATP phosphorylation is used as the assay method.
Moreover, these findings are difficult to match with the suggestion of
Asano et al. (1997)
that Glu820 is directly involved in SCH
28080 binding, and they make it likely that a more complex mechanism
must exist for SCH 28080 inhibition.
|
In addition, we recently demonstrated (Swarts et al., 1998
) that all
three K+-insensitive mutants (E820Q, E820N, and E820A) had
an ATPase activity in the absence of K+. This constitutive
ATPase activity of these mutants could be inhibited by SCH 28080 with
similar IC50 values (0.2-0.7 µM) as that of the
wild-type enzyme (0.4 µM) and the E820D mutant (0.3 µM; see Table
1). In that study, we also measured phosphorylation and
dephosphorylation at 21°C and found that the
K+-insensitive mutants had a high spontaneous
dephosphorylation rate that could not be further stimulated by
K+.
The purpose of the present study is to provide a solution for these
apparently contradictory findings. Why does SCH 28080 inhibit the
ATPase activity (measured at 37°C) of all mutants with a rather
similar affinity, whereas the IC50 values for reduction of
phosphorylation at 0°C vary so much? To give a framework for the
experiments to be described, a simplified version of the Post-Albers model for P-type ATPases is given in Fig.
1. This model takes into account that
both the E2 form and the E2-P form of gastric H+,K+-ATPase are able to react with SCH 28080 (Keeling et al., 1989
; Mendlein and Sachs, 1990
; Van der Hijden et al.,
1991
).
|
The present study shows that the K+-insensitive mutants have a high tendency for the E1 form, in particular at 21°C, and therefore do not bind SCH 28080 very well under nonphosphorylating conditions. Importantly, under ATP-hydrolyzing conditions, they are temporarily in the E2-P form, which does bind SCH 28080. During each catalytic cycle, part of the enzyme is thus trapped by SCH 28080 and therefore inhibited. The lack of reduction of the ATP phosphorylation level by SCH 28080 of mutant E820Q does not mean that residue Glu820 is directly involved in SCH 28080 binding, but only indicates the very low tendency of this mutant for the E2 conformational state of the enzyme.
| |
Materials and Methods |
|---|
|
|
|---|
Preparation of Mutants.
Rat gastric
H+,K+-ATPase was expressed in Sf9 cells as
described previously (Klaassen et al., 1993
; Swarts et al., 1996
). The BaculoGold transfer vector pAcUW51 (Pharmingen, San Diego, CA), containing the full length cDNA of the rat
H+,K+-ATPase
- and
-subunits was used for
site-directed mutagenesis (Deng and Nickoloff, 1992
). The obtained
pAcUW51-HK
-wt and pAcUW51-HK
-mutants, with the DNA code of
the
-subunit under control of the polyhedrin promoter and that of
the
-subunit under control of the p10 promoter were used to produce
recombinant viruses. The (mutated) transfer vectors and linearized
AcNPV DNA (BaculoGold DNA) were co-transfected in Sf9 cells according
to the instructions of the supplier. The viruses obtained by this
method were further purified via a plaque assay, and expression of the
-subunit was screened by Western blotting. The presence of the
desired mutation in the viral genome was checked by sequence and
restriction analysis.
Production of Recombinant
H+,K+-ATPase.
Sf9 cells were grown at
27°C in 100-ml spinner flask cultures (Klaassen et al., 1993
). For
production of H+,K+-ATPase 1.0-1.5 × 106 cells/ml were infected at a multiplicity of infection
of 1 to 3 in the presence of 1% ethanol (Klaassen et al., 1995
) and
incubated for 3 days using Xpress medium (BioWhittaker, Walkersville,
MD) containing additionally 0.1% pluronic F-68 (Sigma, Bornem,
Belgium). By using the latter incubation conditions, both the
phosphorylation capacity and the H+,K+-ATPase
activity of the expressed enzyme were 2 to 3 times higher than
previously found (Swarts et al., 1996
).
Preparation of Sf9 Membranes.
The Sf9 cells were harvested
by centrifugation at 2000g for 5 min. After resuspension at
0°C in 0.25 M sucrose, 2 mM EDTA, and 25 mM HEPES/Tris (pH 7.0), the
membranes were sonicated 3 × 15 s at 60 W (Branson Power
Company, Denbury, CT). After centrifugation for 30 min at
10,000g the supernatant was recentrifuged for 60 min at
100,000g at 4°C. The pelleted membranes were resuspended in the above mentioned buffer and stored at
20°C.
Protein Determination.
Protein was determined with the
modified Lowry method described by Peterson (1983)
using bovine serum
albumin as a standard.
ATP Phosphorylation Capacity.
ATP phosphorylation was
determined as described before (Swarts et al., 1998
). Sf9 cell
membranes (amounts indicated in the legends) were incubated at 0° or
21°C in 50 mM Tris-acetic acid (pH 6.0), 1.2 mM MgCl2,
and 0.2 mM EDTA with and without 0.1 mM SCH 28080 in a volume of 50 µl. After 60-min preincubation, 10 µl of 0.6 µM
[
-32P]ATP was added and incubated for the indicated
time at either 0° or 21°C. The reaction was stopped by adding 5%
trichloroacetic acid in 0.1 M phosphoric acid. The phosphorylated
protein was collected by filtration over a 0.8 µm membrane filter
(Schleicher and Schull, Dassel, Germany). After repeated washing, the
filters were analyzed by liquid scintillation analysis.
Dephosphorylation Studies.
For dephosphorylation studies,
phosphorylation was carried out and the dephosphorylation mixture was
diluted 8.3 times with nonradioactive ATP (final concentration
10 µM) to prevent rephosphorylation with radioactive ATP and was
further incubated for 3 to 30 s at 21°C (Helmich-de Jong et al.,
1985
). The reaction was stopped at the time points indicated and the
amount of E-P was determined as described above.
Analysis of Data.
The IC50 values for SCH 28080 were iteratively determined by fitting the concentration relationship
to the logistic equation Y = A + (B
A)/1 + (10C/10X)D
(A = bottom plateau; B = top plateau; C = IC50; D = Hill coefficient; the values of X and C
were entered as the logarithm of concentration) using the nonlinear
regression computer program InPlot (GraphPAD Software for Science, San
Diego, CA). All data are presented as mean values with S.E.M.
Differences of average were tested for significance by means of
Student's t test.
Chemicals.
[
-32P]ATP (3000 Cimmol
1, Amersham, Buckinghamshire, UK) was
diluted with nonradioactive Tris-ATP (pH 6.0) to a specific
radioactivity of 20 to 100 Cimmol
1. SCH
28080, kindly provided by Dr. A. Barnett (Schering-Plough, Kenilworth,
NJ), was dissolved in ethanol and diluted to its final concentration of
0.1 mM in 0.2% ethanol.
| |
Results and Discussion |
|---|
|
|
|---|
The mechanism of the SCH 28080-induced decrease of the
steady-state ATP phosphorylation level and the ATPase activity of the pig gastric H+,K+-ATPase has previously
been explained with the aid of the adapted form of the
Post-Albers scheme given in Fig. 1 (Keeling et al., 1989
; Mendlein and
Sachs, 1990
; Van der Hijden et al., 1991
). This model will be used as a
framework to explain the behavior of both the wild-type enzyme and the
Glu820 mutants.
SCH 28080 Reduction of the ATP Phosphorylation Capacity.
The
effect of SCH 28080 on the phosphorylation level had previously been
measured by preincubation with the drug for 1 h at 0°C followed
by a 10-s phosphorylation at 0°C using 0.1 µM ATP (pH 6.0) (Hermsen
et al., 1998
). Because we recently observed with some mutants (E820D,
E820Q) that a higher phosphorylation level could be reached at a
(pre)incubation temperature of 21°C (Swarts et al., 1998
),
dose-inhibition curves for SCH 28080 were carried out at both
temperatures. Fig. 2A shows that at 0°C
the wild-type enzyme showed a sigmoid dose-inhibition curve with an IC50 value of 30 nM. At 21°C the dose-inhibition curve
for the wild-type enzyme shifted to the right (IC50 = 0.2 µM), indicating a temperature-sensitive decrease in apparent affinity
for SCH 28080. These findings can be explained by assuming that the
wild-type enzyme is at least partly present in the E2
conformation, which forms an E2-SCH complex during the
preincubation period (reaction
7). As a result, a new equilibrium
between E1
E2
E2-SCH is
achieved, which depends on the SCH 28080 concentration used. Upon
addition of ATP, the residual E1 reacts and
E1-P is formed (reaction +2); this is rapidly converted
into the E2-P conformation (reaction +3). The decrease in
apparent affinity for SCH 28080 upon increasing the temperature from
0° to 21°C might be due to a shift in the E1
E2 equilibrium to the left, resulting in
formation of less E2-SCH complex at suboptimal SCH 28080 concentrations. Alternatively, the increase in temperature might also
shift the E2
E2-SCH equilibrium to the left,
so indirectly resulting in more E1 and, thus, a higher phosphorylation level.
|
E2 equilibrium for this mutant is directed
to the left, E1 is subsequently formed (reaction +1) and
phosphorylation starts again (reactions +2 and +3). It is likely that
after a number of cycles all the enzyme accumulates in the
E2-P-SCH form; this explains the increase in the
phosphorylation level obtained with this mutant.
We suppose that at 0°C the E1
E2
equilibrium for the E820Q mutant is, as for the wild type and all other
mutants, slightly more directed toward the E2 form. We
postulate that the lack of effect of SCH 28080 on the phosphorylation
level might be a combination of a reducing effect (resulting in
E2-SCH) and a stimulatory effect (resulting in the
E2-P-SCH form). In our previous experiments (Swarts et al.,
1996
E2 equilibrium lies more in the direction of E2 than for the E820Q mutant but less as compared with
that of the wild-type enzyme. The part that is in the E2
form cannot be phosphorylated by ATP, whereas the part that is in the
E1 form can be phosphorylated, but might result in the more
stable E2-P-SCH through reaction 5. The final result
is probably a concentration-dependent combination of a decrease of
E2-P and an increase in E2-P-SCH.
Time Course of SCH 28080 Effect.
We investigated the
difference between the effect of high SCH 28080 concentrations on the
phosphorylation level at 21°C for the wild-type enzyme (decrease) and
the E820Q mutant (increase) in more detail by adding 100 µM SCH 28080 15 s after the start of the phosphorylation. Figure
3 shows that addition of SCH 28080 resulted in an immediate decrease in the phosphorylation level of the
wild-type enzyme and in an immediate increase in that of the E820Q
mutant. In both cases a new steady-state level was reached within 20 to
30 s; this level was similar to that obtained when the enzyme was
preincubated for 60 min with SCH 28080 prior to the addition of ATP
(dotted line for E820Q). The rate of equilibrium change is in the same
order of magnitude as described for the binding of SCH 28080 at this
temperature (Keeling et al., 1989
), suggesting that the binding rate
primarily determined the rate of this process.
|
7)
to E2-SCH. Independent of the route, this explains the SCH
28080-induced decrease of the phosphorylation level.
With the E820Q mutant, the E2-P intermediate will in part
be converted into E2-P-SCH and in part be dephosphorylated
into E2. Because of the direction of the
E1
E2 equilibrium E1 will be
formed (reaction +1) and phosphorylation starts again. This will
finally result in an accumulation of E2-P-SCH and thus to an increased phosphorylation level.
Dephosphorylation Kinetics of the Phospho-Intermediates.
If
the above reasoning is correct, the type of E-P obtained with the E820Q
mutant will be different in the absence of SCH 28080 (E2-P)
from that obtained in the presence of SCH 28080 (E2-P-SCH). We therefore studied the dephosphorylation kinetics of the E-Ps obtained under various conditions in the absence of K+.
Figure 4A shows the dephosphorylation
process of the phospho-intermediate of the wild-type enzyme (reaction
4). The measured rate constant at 21°C was 0.08 ± 0.011 s
1 (n = 4). In the presence of 0.1 mM SCH
28080, no E-P was formed.
|
1. The
dephosphorylation rate constants of the phospho-intermediate generated
in the presence of SCH 28080 of the mutants E820A (0.05 ± 0.004 s
1; n = 3) and E820Q (0.05 ± 0.002 s
1; n = 3) were very low, indicating that
a different type of E-P (E2-P-SCH instead of
E2-P) was formed. With the E820A mutant the initial
phosphorylation level was decreased due to partial inhibition of the
phosphorylation process (see Fig. 2B), whereas with the mutant E820Q
the initial phosphorylation level was increased by 100 µM SCH
28080 (see Fig. 2C).
Effects of Inorganic Phosphate, Vanadate, and K+ on the
ATP Phosphorylation Capacity.
Table
2 describes the results from some
additional experiments at 21°C that confirm the model of Fig. 1. In
this table, results with two other mutants (E820D and E820N) are
included. In the absence of SCH 28080 the 10-s phosphorylation level at
21°C varied for these mutants between 2.9 and 5.4 pmol E-P per mg
protein. The observed difference might either be because under these
conditions the maximal phosphorylation level had not been reached for
all mutants or to differences in the amount of correct folded enzyme. It is known, at least for P-type ATPases, that in the baculovirus system, only part of the expressed protein is active (De Tomaso et al.,
1993
; Xie et al., 1996
; Swarts et al., 1996
; Liu and Guidotti, 1997
).
|
E2 equilibrium for the E820N mutant lies
farther in the E2 direction than for the E820A and the
E820Q mutants. The inhibition by SCH 28080 of the phosphorylation level
of the E820N mutant at 21°C is again less than at 0°C (Hermsen et
al., 1998
E2
E2-SCH equilibrium
towards E1.
H+,K+-ATPase can be phosphorylated by inorganic
phosphate on the same aspartyl residue that becomes phosphorylated by
ATP (Van der Hijden et al., 1991SCH 28080 Inhibition in the ATPase Activity Measurements. Under ATP hydrolyzing conditions (37°C and long incubation periods), the wild-type enzyme as well as the Glu820 mutants come temporarily in the E2 or E2-P forms both of which bind SCH 28080. During each catalytic cycle, part of the enzyme is thus trapped by SCH 28080 and therefore inhibited. This explains why the IC50 values of SCH 28080 for the wild-type enzyme and the E820 mutants in the ATPase differ only slightly (Table 1).
Asano et al. (1997)Concluding Remarks.
The present study shows that differences
in sensitivity for SCH 28080 on the ATP phosphorylation level between
various Glu820 mutants of gastric
H+,K+-ATPase are not due to a direct
involvement of Glu820 for SCH 28080 binding, but to
differences in K+-sensitivity and the direction of the
E2
E1 equilibrium. In general, if mutation of
a certain amino acid has an effect on the degree of enzyme inhibition,
it does not prove that the mutated residue is directly involved in
binding of the inhibitor.
| |
Footnotes |
|---|
Received July 7, 1998; Accepted December 2, 1998
This work was sponsored in part by the Netherlands Foundation for Scientific Research, Division of Life Sciences (NWO-ALW) Grant number 805-05-041.
Send reprint requests to: Dr. J.J.H.H.M. De Pont, Department of Biochemistry, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands. E-mail: J.dePont{at}bioch.kun.nl
| |
Abbreviations |
|---|
SCH 28080, 2-methyl-8-[phenylmethoxy] imidazo-(1,2a) pyridine 3-acetonitrile; E-P, phosphorylated intermediate.
| |
References |
|---|
|
|
|---|
-subunit is essential for K+ activation of the enzyme activity.
Biochem J
331:
465-472.This article has been cited by other articles:
![]() |
H. G. P. Swarts, J. B. Koenderink, P. H. G. M. Willems, E. Krieger, and J. J. H. H. M. De Pont Asn792 Participates in the Hydrogen Bond Network Around the K+-binding Pocket of Gastric H,K-ATPase J. Biol. Chem., March 25, 2005; 280(12): 11488 - 11494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Koenderink, H. G. P. Swarts, P. H. G. M. Willems, E. Krieger, and J. J. H. H. M. De Pont A Conformation-specific Interhelical Salt Bridge in the K+ Binding Site of Gastric H,K-ATPase J. Biol. Chem., April 16, 2004; 279(16): 16417 - 16424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Watts, A. Watts, and D. A. Middleton A Model of Reversible Inhibitors in the Gastric H+/K+-ATPase Binding Site Determined by Rotational Echo Double Resonance NMR J. Biol. Chem., November 9, 2001; 276(46): 43197 - 43204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Koenderink, H. P. H. Hermsen, H. G. P. Swarts, P. H. G. M. Willems, and J. J. H. H. M. De Pont High-affinity ouabain binding by a chimeric gastric H+,K+-ATPase containing transmembrane hairpins M3-M4 and M5-M6 of the alpha 1-subunit of rat Na+,K+-ATPase PNAS, September 29, 2000; (2000) 200109597. [Abstract] [Full Text] |
||||
![]() |
H. G. P. Swarts, J. B. Koenderink, H. P. H. Hermsen, P. H. G. M. Willems, and J. J. H. H. M. De Pont K+-independent Gastric H+,K+-ATPase Activity. DISSOCIATION OF K+-INDEPENDENT DEPHOSPHORYLATION AND PREFERENCE FOR THE E1 CONFORMATION BY COMBINED MUTAGENESIS OF TRANSMEMBRANE GLUTAMATE RESIDUES J. Biol. Chem., September 28, 2001; 276(40): 36909 - 36916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Koenderink, H. P. H. Hermsen, H. G. P. Swarts, P. H. G. M. Willems, and J. J. H. H. M. De Pont High-affinity ouabain binding by a chimeric gastric H+,K+-ATPase containing transmembrane hairpins M3-M4 and M5-M6 of the alpha 1-subunit of rat Na+,K+-ATPase PNAS, October 10, 2000; 97(21): 11209 - 11214. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||